The Johnson and Johnson, Dentsu and Koch Industries-backed diagnostics device developer priced its initial public offering in the middle of its range.

Sleep apnoea treatment developer Cryosa raised $21m in a Hoya-backed series B round while CommerzVentures led a $17m round for financial tool developer Doconomy .

Co-founded by Harvard faculty, Garuda has launched with $72m in series A financing to advance blood stem cell therapies.

SoftBank Vision Fund 2 led a series C round for the life science robotics developer at a reported valuation of $1.8bn.

Ackermans & van Haaren and MSIVC have returned to back the medical supplies marketplace’s latest round, which reportedly valued it at above $235m post-money.

Mass General Brigham Ventures was among the participants in a series A round announced at the launch of the blood stem cell-focused startup.

SoftBank Vision Fund 2 helped microbial therapeutics developer Hexagon tip its overall funding to over $108m.

Acromec Engineers has helped its incubator affiliate create a co-working establishment for medtech, biotech and foodtech startups’ R&D initiatives.

Oxygen therapy developer Aviv Scientific completed a $40m series B round led by Danel while drug delivery system developer Credence raised almost as much.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.